ORDER NOW

Single-site or operational unit license 
$2,500.00 

Global enterprise-wide license PDF:  
$5,000.00 

Country or Global license 
Contact David Cunningham, 
Account Manager, 
781-972-5472 
cunningham@
healthtech.com

Length 
84 pages 

Date published 
September 2006 

Additional info 
Single-site, country, and global licenses are multi-user, searchable, and cut-and-paste ready PDFs delivered by e-mail.

Comparative Genomic Hybridization: Current State and Future Directions 

Ricki Lewis, PhD 

New Page 1

CHI Advances Comparative Genomic Hybridization Survey –

  1. Please classify your organization.
  2. Please classify how you organization is involved with CGH.
  3. If your use of CGH is in basic research, please indicate the appropriate field(s).
  4. If you application of CGH is clinical, please indicate the appropriate field(s).
  5. If you use CGH in reproduction research, please indicate which field(s) your laboratory investigates or which technique it utilizes.
  6. If you use CGH to investigate inherited developmental disorders, please indicate which one(s) are studied in your laboratory.
  7. If you use CGH in cancer research, please indicate in which area(s) your lab applies CGH.
  8. Please indicate which type(s) of cancers your laboratory analyzes using CGH.
  9. When do you think that copy number will become part of clinical testing beyond investigational uses?
  10. Do you think that CGH holds greater promise than SNP genotyping as a means of enabling personalized medicine?
  11. Which of the following products do you use in CGH research?
  12. Do you assemble components or use a multistep kit?
  13. Do you use a system that also incorporates genotyping?
  14. Do you use a system that also incorporates gene expression analysis?
  15. What factor(s) do you consider when selecting products and devices for CGH experiments?
  16. What is(are) your source(s) of cells?
  17. Which method(s) of DNA amplification do you use with CGH?
  18. Which fluorescent DNA labels do you use with CGH?
  19. If you use microarrays, please indicate how extensive their coverage(s) is(are).
  20. What elements are on you CGH microarrays?
 


About Insight Pharma Reports

How to Order

Journalist Inquiries

Corporate Librarians and Information Services Inquiries

The Insight Pharma Reports Advisory Board

Contact Insight Pharma Reports

 

"CHI's Insight
 Pharma Reports are
 a cost-effective and reliable source
 of information about the markets
 we serve. The cost
 for us to conduct
 this kind of business
 research on our
 own would be
 prohibitive. CHI's
 Insight Pharma
 Reports allow us to
 keep on top of
 developments in
 this rapidly moving
 field." 

--Donald N. Halbert, Ph.D., EVP of R&D, Iconix Biosciences

 

A division of 
Cambridge 
Healthtech Institute


CHI's Insight Pharma Reports, a division of Cambridge Healthtech Institute | 250 First Avenue | Needham, MA 02494
For more information, email Rose LaRaia at rlaraia@healthtech.com or call 781-972-5444